Quantinno Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quantinno Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,606	Closed	-$740K	–	2643
2025 Q1	$740K	Buy	5,606 +2,544	+83%	+$317K	﹤0.01%	1256
2024 Q4	$256K	Buy	+3,062	New	+$252K	﹤0.01%	1446

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quantinno Capital Management's ITCI Position: Q2 2025 in Review

Quantinno Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,606 shares — an estimated $740K sold.

Quantinno Capital Management first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $740K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Quantinno Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Quantinno Capital Management sold 5,606 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $740K.
Quantinno Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Quantinno Capital Management's Intra-Cellular Therapies Inc. position peaked at $740K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Quantinno Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.